Barinthus Biotherapeutics (BRNS)

• Market cap: $29.6M
• 1 day: 2.1%
• 5 days: 8.53%
• 1 month: 3.16%
• 3 months: -54.11%
• 6 months: -21.82%
• Year to date: -1.36%
• 1 year: -36.96%
• 5 years: -94.86%
• 10 years: -94.86%
• Sector: Healthcare
• Industry: Biotechnology

About: Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Employees: 105